Last reviewed · How we verify
NCT05858372: MASTIHA-OIL
Effects of Chios Mastiha Essential Oil on Cholesterol Levels of Healthy Volunteers
NA trial testing Chios Mastiha essential oil in Hyperlipidemias in 160 participants. Completed in 30 September 2022.
30 September 2022
Quick facts
| Lead sponsor | AHEPA University Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 160 |
| Start date | 1 July 2022 |
| Primary completion | 30 September 2022 |
| Estimated completion | 30 September 2022 |
| Sites | 1 location across Greece |
Drugs / interventions tested
- Chios Mastiha essential oil
- Placebo
Conditions studied
- Hyperlipidemias — all drugs for Hyperlipidemias →
- Hypercholesterolemia — all drugs for Hypercholesterolemia →
Sponsor
AHEPA University Hospital
Who can join
18 and older, any sex, with Hyperlipidemias or Hypercholesterolemia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A prospective, randomized, placebo-controlled study was designed to study the hypolipidemic effect of CMO capsules on healthy volunteers with elevated cholesterol levels.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05858372
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Hyperlipidemias
Currently open trials in the same condition.
- NCT06903897 — Social Needs Screening and Chronic Diseases Study (WE CARE) · NA · recruiting
- NCT06049420 — Lifestyle Medicine: Establishing Clinical Approaches to Chronic Disease for Rural Patients · NA · recruiting
- NCT06461273 — Food is Medicine vs Lifestyle Medicine For Cardiovascular Kidney Metabolic (CKM) Syndrome · NA · active not recruiting
- NCT06094491 — Virtual Diabetes Group Visits Across Health Systems · Phase 2 · active not recruiting
- NCT06055036 — Black Impact: The Mechanisms Underlying Psychosocial Stress Reduction in a Cardiovascular Health Intervention · NA · recruiting
Other AHEPA University Hospital trials
Trials by the same sponsor.
- NCT07519850 — The Impact of Perianal Disease on Patient's Sex Life · recruiting
- NCT06812455 — Effect of RIVAroxaban in Radial Artery Occlusion Treatment After Cardiac Catheterization · Phase 4 · recruiting
- NCT05176769 — Artificial Intelligence for Automated Clinical Data Exploration From Electronic Medical Records (CardioMining-AI) · recruiting
- NCT04186676 — Myocardial Infarction With Non-Obstructive Coronary Arteries in the Greek Population · completed
- NCT04058860 — Study of Microcirculation During Extracorporeal Circulation in Cardiac Surgery · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05858372 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by AHEPA University Hospital
- Last refreshed: 15 May 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05858372.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing